Infinity Pharmaceuticals' (INFI) CEO Adelene Perkins on Q3 2016 Results - Earnings Call Transcript

11/10/16

Infinity Pharmaceuticals, Inc. (NASDAQ:INFI)

Q3 2016 Earnings Conference Call

November 9, 2016 4:30 PM ET

Executives

Jaren Madden – Senior Director-Investor Relations and Corporate Communications

Adelene Perkins – President and Chief Executive Officer

Julian Adams – President-Research and Development

Joe Pearlberg – Medical Lead-IPI-549 program

Larry Bloch – Executive Vice President, Chief Financial Officer and Chief Business Officer

Analysts

Andrew Tsai – RBC Capital

Katherine Xu – William Blair

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.